Vidofludimus
Vidofludimus (SC12267, 4SC-101) is an orally active and potent dihydroorotate dehydrogenase (DHODH) inhibitor with IC50 of 134 nM for human DHODH. Vidofludimus calcium (IMU-838) is investigated as a potential treatment option for COVID-19. Phase 2.
| Trivial name | SC12267, 4SC-101 |
| Catalog Number | S7262 |
| Molecular Formula | C20H18FNO4 |
| CAS# | 717824-30-1 |
| Inchi | InChI=1S/C20H18FNO4/c1-26-14-5-2-4-12(10-14)13-8-9-18(17(21)11-13)22-19(23)15-6-3-7-16(15)20(24)25/h2,4-5,8-11H,3,6-7H2,1H3,(H,22,23)(H,24,25) |
| Inchi Key | XPRDUGXOWVXZLL-UHFFFAOYSA-N |
| SMILES | COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)O)F |
| Size | 5mg |
| Supplier Page | http://www.selleckchem.com/products/vidofludimus.html |
| Additional Information | https://file.selleck.cn/downloads/struct/vidofludimus-chemical-structure-s7262.gif |